GENMAB A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,808.75 DKK | +0.49% |
|
-2.56% | -16.15% |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 17 | |||||||||
| 29 | |||||||||
| 25 | |||||||||
| 15 | |||||||||
| 18 | |||||||||
| 21 | |||||||||
| 18 | |||||||||
| - | - | - | 7 | ||||||
| 16 | |||||||||
| 25 | |||||||||
| 19 | |||||||||
| 7 | |||||||||
| 19 | |||||||||
| - | - | - | - | ||||||
| 10 | |||||||||
| 21 | |||||||||
| - | 13 | ||||||||
| 4 | |||||||||
| 21 | |||||||||
| Average | 17 | ||||||||
| Weighted average by Cap. | 22 |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition